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ABSTRACT
Objective To compare the reporting of essential





Study selection All articles of comparative studies
assessing total hip or knee arthroplasty carried out by a
minimally invasive approach or computer assisted
navigation system.
Data extraction Items judged to be essential for
interpreting the applicability of findings about such
procedures were identified by a survey of a sample of
orthopaedic surgeons (77 of 512 completed the survey).
Reports were evaluated for data describing these
“essential”itemsandthenumberofcentresandsurgeons
involvedinthetrials.Whendataonthenumberofcentres
and surgeons were not reported, the corresponding
author of the selected trials was contacted.
Results 84 articles were identified (38 randomised
controlled trials, 46 non-randomised studies).
The medianpercentage (interquartile range) of essential
items reported for non-randomised studies compared
with randomised controlled trials was 38% (25-63%)
versus 44% (38-45%) for items about patients,
71% (43-86%) versus 71% (57-86%) for items
considered essential for all interventions,
and 38% (25-50%) versus 50% (25-50%) for items
about the context of care. More than 80% of both study
t y p e sw e r es i n g l ec e n t r es t u d i e s ,w i t ho n eo rt w o
participating surgeons.
Conclusion The reporting of data related to the
applicability of results was poor in published articles of
bothnon-randomisedstudiesandrandomisedcontrolled
trials and did not differ by study design. The applicability
of results from the trials and studies was similar in terms
of number of centres and surgeons involved and the





specialty of surgery, however, results of such trials are
oftencriticisedforbeingpoorlyapplicable.Theresults
of non-randomised studies are believed to have better
applicability.
3-8
Applicability (also called external validity or
generalisability)
9 concerns a multidimensional con-
cept depending on the extent to which participants,
the context of care, and the interventions (and com-
parators) evaluated in studies are representative of, or
canbereproducedin,usualcare.Theapplicabilityofa
trial’sresultscouldbelimitedifpatientsrepresentonly
a small proportion of those being treated in normal
practice.
10 The participation of centres with different
resources and surgeons with different skills may
mean that treatment effects observed in research may
not be applicable, or at worst are irrelevant, to non-
research settings.
11-15 Surgical procedures are complex
interventions that can be difficult to describe, standar-
dise, and reproduce consistently in clinical practice.
16
Appraising the applicability of the results of a study
isintertwinedwiththequalityofreporting—thatis,the
extent to which an article provides information about
the patients, the intervention, and the context of care
(centres and surgeons’ expertise). Articles often omit
important details. Poor reporting of applicability data
by researchers may be a barrier to applying research
findings in clinical practice.
We tested empirically the hypothesis that non-ran-
domised studies yield results that are more applicable
thanthoseofrandomisedcontrolledtrials.Forthispur-
pose we identified items considered by surgeons to be




ber of centres and surgeons involved) in published
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We focused on minimally invasive and computer
assisted navigation techniques for total hip arthro-
plasty and total knee arthroplasty. These surgical pro-
cedures were chosen because they have been
developed recently, are complex, and their success
depends on patient selection, surgeon experience,




randomised controlled trials and non-randomised stu-
dies that assessed four surgical procedures: minimally
invasive and computer assisted navigation techniques
for total hip arthroplasty and total knee arthroplasty.
Next, we surveyed orthopaedic surgeons to identify
itemsconsideredessentialinassessingtheapplicability
of evidence for these procedures to clinical practice.
We extracted data on the reporting of essential applic-
ability items using standardised methods and com-
pared the quality of reporting for non-randomised
studies and randomised controlled trials. Finally, we
extracted data on the context of care (number of cen-
tres and surgeons involved) and compared the applic-
ability of the context of care for non-randomised
studies and randomised controlled trials.
Search for and selection of eligible studies
We searched for all English language articles of trials
thatevaluatedminimallyinvasiveorcomputerassisted
totalhiparthroplastyortotalkneearthroplastyinMed-
line and the Cochrane central register of controlled
trials(seewebextraappendix1fordetailsofthesearch
strategy). One author (LP) screened the titles and
abstracts of retrieved citations to select the relevant
articles. The a priori inclusion criteria were all rando-
mised and non-randomised studies that compared
total hip arthroplasty or total knee arthroplasty done
by a minimally invasive approach or a computer
assisted navigation system with one or more conven-
tional procedures. We also included trials that evalu-
ated minimally invasive procedures involving
computer assisted navigation techniques.
Aprioriexclusioncriteriawereuncontrolledstudies,
non-therapeutic studies (in vitro, biomechanical, and
epidemiological studies), pathophysiological studies,
letters, ancillary studies such as a subgroup analysis,
studies that compared two minimally invasive proce-
duresortwocomputerassistednavigationprocedures,
cost effectiveness evaluations, and systematic reviews
or meta-analyses. We also excluded studies that
assessed the organisation of the healthcare system or
interventions provided to care providers. When more
than one article was retrieved for the same study, we
considered only the earliest publication as eligible.
Weusedastandardisedformtoextractdataforeach
eligible study (see web extra appendix 2): year of pub-
lication, type of surgical procedure (total hip arthro-
plasty or total knee arthroplasty, minimally invasive
or navigation procedure), study design (randomised
controlled trial, non-randomised historically con-
trolled study, case-control study, or other non-rando-
mised comparative study), sample size, whether a
statistician or methodologist was included among the
authors, the risk of bias, and items essential to inter-
preting the applicability of the findings.
Identification of items essential for interpreting applicability
To identify items relevant to applicability, we carried
out a literature search, relying especially on criteria
proposed by the CONSORT statement and its exten-






intervention (for practical reasons we did not focus on
the description of the comparator), and the context of
care (centres and care providers).
In a second step we invited by email experts to parti-
cipateinawebbasedsurvey:allcorrespondingauthors
ofpublishedarticlesofstudies(withnorestrictiononthe
design) that assessed knee arthroplasty or hip arthro-
plasty identified by an electronic search strategy (see
web extra appendix 4) and all members of the French
HipandKneeSociety(SFHG,createdin1997andcon-
sisting of 100 orthopaedic surgeons specialising in hip
and knee surgery). For each item, surgeons had to indi-
cate whether they agreed, on a scale of 1 (totally dis-
agree) to 9 (totally agree), that the item should be
reported in a published article of a trial. Surgeons
could also indicate any other items that were not listed
but were deemed important. The criterion used to clas-
sify an item as being “essential” for adequate appraisal
Articles identified through electronic search (n=207)
Selected on basis of title and abstract (n=115)
Studies included in final review (n=84)
Non-randomised studies (n=46)
  Minimally invasive procedures (n=21)
  Navigated procedures* (n=17)
  Minimally invasive procedures +
    navigated procedures* (n=8)
 
Randomised controlled trials (n=38)
  Minimally invasive procedures (n=11)
  Navigated procedures* (n=25)
  Minimally invasive procedures +






















Excluded on basis of title or abstract (n=92)
Excluded on basis of full text (n=31):
  Ancillary studies (n=4)
  No experimental group of interest (n=6)
  In vitro studies (n=3)
  Non-comparative studies (n=4)
  Duplicate publications (n=14)
Fig 1 | Flow of selected articles through study
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wasascoreof7ormoreby50%ormoreofrespondents.
Wedidnotinviteotherimportantstakeholderssuch
as patients or policymakers because surgeons are
usually the first line in appraising to whom and in
which context trial results should be applied.
Extracting data on essential applicability items
One author (LP) appraised the reporting of essential
applicabilityitemsusingastandardiseddataextraction
form (see web extra appendix 2). The author also
assessed whether applicability was considered in the
discussion section. A random sample of 15% of the
selected articles was reviewed independently by
another author (IB) for quality assurance (see web
extra appendix 5 for the proportion of agreement
between the two reviewers). Items with a low level of
agreement were discussed and, if necessary, all
selected articles were reappraised after discussion.
We calculated the proportion of essential items
reported for three components of applicability:
description of the patients, description of the experi-
mental intervention, and context of care.
Context of care
As well as evaluating the reporting of applicability
data, we aimed to appraise the actual applicability of
the resultsof the selectedtrials.Becauseappraisingthe
applicability of published results of a study is difficult,
we focused on only some components related to the
context of care—the number of centres and number
of surgeons involved in the randomised controlled
trials and non-randomised studies, assuming that stu-
dies with a low number of participating centres and
surgeons had low applicability. When the number of
centres and participating surgeons was not reported in
selected articles, we contacted the corresponding
author by email for this information. When authors
didnotrespondweassumedthatthenumberofcentres
corresponded to the number of orthopaedic centres
reported in the affiliations of the article, and the num-
ber of surgeons was treated as missing.
Statistical analysis
Categorical variables are described with frequencies
and percentages, and quantitative variables with med-
ians (interquartile ranges).
To compare the reporting of applicability of the
resultsofthetwostudytypes,wecalculatedthepercen-
tage of applicability items reported, from 0 (no item
reported) to 100 (all items reported), for each trial for
the three domains of patients, experimental inter-
vention,andcontextofcare.Wecomparedthepercen-
tage of applicability items reported for randomised
controlled trials and non-randomised studies by a
non-paired Wilcoxon test. The level of significance
was set at P<0.05.
Applicability assessments are described with fre-
quencies and percentages. All data analyses were
doneusingtheR2.8.0softwarepackage(RFoundation
for Statistical Computing, Vienna, Austria).
RESULTS
The search strategy generated 207 articles: 84 were eli-
gible and appraised (fig 1). Thirty eight studies were
randomised controlled trials and 46 were non-rando-
mised studies. Thirty four studies assessed total hip
arthroplastyand50totalkneearthroplasty.Theexperi-
mental procedure was a minimally invasive one in 32
studies,acomputerassistednavigationtechniquein42,
and a computer assisted navigation technique asso-
ciated with a minimally invasive procedure in 10.
Characteristics of selected studies
Table 1 details the general characteristics of the
selected articles. Articles were published between










Median sample size (interquartile range):
No of patients 92 (60-131) 90 (60-120)
No of hips or knees undergoing surgery 90 (78-132) 95 (60-148)
Designs of non-randomised studies:
Controlled cohort 30 (65) —
Historically controlled 14 (30) —
Case-control 2 (4) —
Justification for absence of randomisation 2 (4) —
Main outcome reported 18 (39) 23 (61)
Radiographic findings (for example, implant positioning)* 17 (94) 20 (87)
Length of follow-up (months):
Not reported 10 (22) 7 (18)
≤3 15 (33) 20 (53)
3-6 6 (13) 5 (13)
6-12 9 (20) 1 (3)
12-24 4 (9) 3 (8)
>24 2 (4) 2 (5)
Patients’’ selection bias
Non-randomised studies:
Patients recruited from same population 20 (44) —
Consecutive series of patients grouped 16 (35) —
Attempts to balance groups by design (matching) 15 (33) —
Randomised controlled trials:
Generationofallocationsequencereportedandadequate — 18 (47)
Treatment allocation concealmentreported and adequate — 0
Groups comparable at baseline 32 (70) 33 (87)
Analysis adjusted for important confounders 1 (2) 3 (7.9)
Evaluation bias
Blinded outcome assessor 15 (33) 19 (50)
Independent outcome assessor (when not blinded) 11 (24) 5 (13)
Monitoring procedure reported 0 4 (11)
Attrition bias
All patients analysed 6 (13) 8 (21)
Rate of missing data reported 1 (2) 2 (5)
Methods to handle missing data reported 0 0
*Occurrence of radiographic main outcomes over all types of main outcomes.
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tions in 2005 and 2006.
Themedian(interquartilerange)numberofpatients
for non-randomised studies was 92 (60-131) and for
randomised controlled trials was 90 (60-120). Thirty
(65%) non-randomised studies were controlled cohort
studies, 14 (30%) historically controlled studies, and 2
(4%) case-control studies. Eleven (37%) controlled
cohort studies were clearly reported as being prospec-
tive.Thecomparatorwassystematicallyanothersurgi-
cal procedure.
A primary outcome was clearly reported for 39% of
non-randomised studies (n=18) and 61% of rando-
mised controlled trials (n=23) and, when reported,
was radiographic in 93% of reports (n=37). The dura-
tion of follow-up, when reported, was no longer than
oneyear in 84% (56/67)of the articles.Adverse events
were reported for 70% of non-randomised studies
(n=32) and 61% of randomised controlled trials
(n=23). A definition of severe adverse events was
given in the reports of only three non-randomised stu-
dies (7%) and two randomised controlled trials (5%).
Survey of surgeons
Of the 512 experts contacted by email, 87 completed
the web based survey. Respondents who were not
orthopaedic surgeons (n=10) were excluded (see web
extra appendix 6 for the flow of experts and web extra
appendix7foradescriptionoftheseparticipants).The
results of the survey are summarised in web extra
appendix 8. Eight items were classified as essential for
patientcharacteristicsandfourforcontextofcare(cen-
tresandsurgeons).Theseitemsdidnotdifferaccording
to the procedure evaluated. Essential items describing









































































































































































Fig 2 | Proportion of essential items (rated ≥7 on 0-9 scale by
>50% of surgeons) reported by non-randomised studies and
randomised controlled trials. Minimally invasive navigated
procedures were excluded (n=10) because relevance of items
for interventions were selected for minimally invasive or
navigated technique. Solid line is median of distribution, and
upper and lower ends of box are upper and lower quartiles of
data. Whiskers extend to most extreme values within 1.5
times interquartile range











Baseline clinical characteristics of patients: 77 (92) 40 (87) 37 (98)
Age 74 (88) 38 (83) 36 (95)
Sex 68 (81) 34 (74) 34 (90)
Body mass index 50 (60) 23 (50) 27 (71)
Underlying disease for THA or TKA indication 43 (51) 27 (59) 16 (42)
Functional status 25 (30) 14 (30) 11 (29)
Preoperative pain 3 (4) 1 (2) 2 (5)
Patient’s preoperative deformity 14 (17) 10 (22) 4 (11)
Comorbidities 14 (17) 6 (13) 8 (21)
Setting and centre:
No of centres 35 (42) 16 (35) 19 (50)
Centres’ surgical volume 2 (2) 2 (4) 0
No of surgeons 68 (81) 37 (80) 31 (82)
Data on surgeons’ experience 35 (42) 16 (59) 19 (50)
Generic items selected for all interventions:
Surgical approach 56 (67) 30 (65) 26 (68)
Duration of intervention 58 (69) 30 (65) 28 (74)
Prosthesis implanted 67 (80) 33 (72) 34 (90)
Brand name of prosthesis 66 (79) 33 (72) 33 (87)
Type of fixation 58 (69) 30 (65) 28 (74)
Rehabilitation programme 29 (35) 17 (37) 12 (32)
Length of hospital stay 24 (29) 15 (33) 9 (24)
THA=total hip arthroplasty; TKA=total knee arthroplasty.
*More than 50% of respondents rated these items as 7 or more on 0-9 scale in survey of sample of surgeons.
RESEARCH
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mally invasive and computer navigated total hip
arthroplasty and total knee arthroplasty) and nine
items were selected specifically for minimally invasive
procedures and seven for navigated procedures.
Reporting of essential applicability items
Tables 2 and 3 and figure 2 describe the reporting of
essential applicability items.
The median proportion (interquartile range) of
essentialitemsfornon-randomisedstudiesandforran-
domised controlled trials for the description of partici-
pantswas38%(25-63%)and44%(38-45%;P=0.60),for
the description of the experimental intervention was
71% (43-86%) and 71% (57-86%; P=0.68), for the gen-
ericitemswas50%(33-75%),andforspecificitemswas
67% (49-75%; P=0.27).
The median proportion (interquartile range) of
essential items describing the context of care for non-
randomised studies and for randomised controlled
trials was 38% (25-50%) and 50% (25-50%; P=0.17).
The number of centres reported for non-randomised
studieswas35% (n=16) and forrandomisedcontrolled
trialswas50%(n=19).Detailssuchasvolumeofcarein
thecentrewerereportedforonlytwonon-randomised
studies (4%). Details on surgeons’ expertise were
reported for 59% of non-randomised studies (n=16)
and 50% of randomised controlled trials (n=19).
When reported, these details described years of prac-
tice for only one non-randomised comparative study
(6%) and one randomised controlled trial (5%) and
the number of experimental interventions carried out
beforethestartofthestudyfor50%ofnon-randomised
studies (n=8) and 55% of randomised controlled trials
(n=11). For 38% of non-randomised studies (n=6) and
30%ofrandomisedcontrolledtrials(n=6)thesurgeons
were reported as “experts,” without any further detail.
Finally, issues with applicability were discussed in
thediscussionsectionof22%ofthearticlesofnon-ran-
domised studies (n=10) and 21% of those of rando-
mised controlled trials (n=8).
Context of care
The context of care was evaluated by comparing the
numberofsurgeonsandcentresinvolvedintherando-
mised controlled trials and non-randomised studies.
After we contacted the corresponding authors, the
number of participating surgeons was known for 81%
of the studies (n=68). Data on the number of centres
were available for 58 studies (69%). For the remaining
26studies,thenumberoforthopaediccentresreported
in the affiliations was considered.
Figure 3 describes the reported and actual number of
participatingcentresandsurgeonsinthetrials.Theactual
number of centres did not differ according to study
design because most trials were carried out in only one
centre: 82% of non-randomised studies (n=37) and 87%
of randomised controlled trials (n=33). The actual num-
ber of participating surgeons was comparable between
the two study types. One or two surgeons participated
in 80% of the non-randomised studies (n=37) and in
82% of the randomised controlled trials (n=31).
DISCUSSION
Our appraisal of 84 articles of non-randomised studies
(n=46) and randomised controlled trials (n=38) that
Table 3 |Reporting of essential items describing intervention specific to procedure evaluated*. Values are numbers
(percentages)





Items selected for minimally invasive procedures: n=32 n=21 n=11
Information provided to patients 3 (9) 1 (5) 2 (18)
Preoperative care 1 (3) 0 1 (9)
Anaesthesia protocol 11 (34) 7 (64) 4 (36)
Thromboprophylaxis protocol 6 (19) 5 (24) 1 (9)
Length of incision 26 (81) 17 (81) 9 (82)
Description of instrumentation† used in minimally invasive procedures 22 (69) 15(71) 7 (64)
Postoperative pain management protocol 8 (25) 4 (19) 4 (36)
Blood loss‡ 22/24 (92) 15/16 (94) 7/8 (88)
Antibioprophylaxis protocol‡ 3/24 (13) 2/16 (13) 1/8 (13)
Items selected for computer assisted navigation procedures: n=42 n=17 n=25
Description of navigation system 41 (98) 17 (100) 24 (96)
Brand name of navigation system 41 (98) 17 (100) 24 (96)
Type of navigation system (image based or imageless) 35 (83) 15 (88) 20/26 (7)
Characteristics of navigation system (open or closed) 2 (5) 1 (6) 1/26 (4)
Blood loss§ 2/5 0/1 2/4
Postoperative pain management protocol§ 0/5 0/1 0/4
Reports of trials assessing minimally invasive navigated procedures were excluded: non-randomised studies (n=4) and randomised controlled trials
for total hip arthroplasty (n=1) and total knee arthroplasty (n=1).
*More than 50% of respondents rated these items 7 or more on 0-9 scale in survey of sample of surgeons).
†Standard or specific.
‡Only for minimally invasive total hip arthroplasty (n=24).
§Only for computer assisted total hip arthroplasty (n=5).
RESEARCH
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arthroplasty or total knee arthroplasty carried out by
a minimally invasive approach or computer assisted
navigation system) does not support the hypothesis
that, in general, results of non-randomised studies
havebetterapplicabilitythanthoseofrandomisedcon-
trolled trials. The reporting of items judged “essential”
fordeterminingapplicabilitydidnotdifferbetweenthe
two study designs. Important components of the inter-
vention itself, such as protocols for preoperative care
or management of pain, were rarely described. The
proxy used to evaluate the applicability related to the
contextofcare—thenumberofsurgeonsandcentres—
was similar between the trial types as well. Other fac-
tors potentially affecting actual applicability, such as
the relevance of a radiographic primary outcome and
durationoffollow-upoflessthanoneyear,alsodidnot
differ by study design and limited the applicability of
the results of the selected studies. Our results suggest
that some reports of both non-randomised studies and
randomisedcontrolledtrialsmaybeofuncertainvalue
to surgeons, researchers, systematic reviewers, and
decision makers.
Theseresultsinevitablypromptthequestionofwhy.
Controlled studies in other healthcare specialties vary
on a spectrum of “pragmatism” or “efficacy/effective-
ness,” addressing research questions focused on clini-
cal or policy decisions or mechanisms of action.
19 Are
ourfindingsevidenceofgeneraldisinterestamongsur-
geons about pragmatic questions or were the inter-
ventions reviewed here too new? Some examples of
nationallyrepresentativestudiesonsurgicaloutcomes,
such as those involving national arthroplasty registers,
may provide useful data, but such studies make up a
tiny fraction of the surgical literature. In fact, no pub-
lished articles evaluating the selected procedures used
data from a national register or similar database with
wide coverage. Furthermore, studies carried out in
other specialties highlight the challenges of inter-
preting the findings of non-randomised studies invol-
ving a nationally representative sample.
2021
How could we improve the situation? Applicability
must be considered as it is usually done for internal
validity at different steps of the trial: in the protocol,
when deciding the eligibility criteria for the centres,
surgeons, and patients but also when reporting the
trial results by following the CONSORT statement,
22
particularly the extension for non-pharmacological
treatments.
17 To tackle the question of the impact of
the surgical learning curve, for instance, one author
recommendedthat “surgical trialsshould report expli-
citly and informatively on the prior expertise of the
participating surgeons.”
23
Our results on applicability reporting are consistent
withthoseforothertrials,highlightingthatauthorspay
insufficient attention toapplicability in theirpublished
articlesofrandomisedcontrolledtrials.
824However,to
our knowledge this is the first study to compare the
reportingofapplicabilitydatainreportsofrandomised
controlled trials and non-randomised studies. Further-
more, we took into account that applicability criteria
vary depending on the procedure evaluated. In our
study, orthopaedic surgeons contributed to the selec-







































































































Actual No of centres* and surgeons



















































Fig 3 | Number of participating centres and surgeons in
randomised controlled trials and non-randomised studies
assessing minimally invasive technique and computer
assisted navigated technique for total knee arthroplasty and
total hip arthroplasty. *When number of centres was not
reported in text or available from author then number of
centres reported in affiliations was chosen
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The study has several limitations. Firstly, we focused
onstudiesassessingthe specificproceduresoftotalhip
arthroplasty and total knee arthroplasty, and these
results should be confirmed in other surgical areas.
However, we chose recent interventions that are
increasinglybeingusedinclinicalpractice.Thischoice
also allowed for a detailed and precise assessment of
applicability. Secondly, we focused on the reporting
of essential applicability information for randomised
controlledtrialsandnon-randomisedstudiesandeval-
uated the actual applicability of the results of the stu-
diesmainlyfromdatarelatedtothecontextofcare.We
were unable to compare the representativeness of
patientsinreportsofbothstudydesignsbecauseessen-
tial information was often missing. Thirdly, for practi-
cal reasons we evaluated the context of care by
focusing only on the centres and surgeons. Finally,
we assumedthatinvolvementof morecentresand sur-
geons implies better applicability of results, but this
assumption is not true when all participating centres
and surgeons have high expertise. However, our
results highlighted that most trials involved only one
centreandoneortwosurgeons,andtheapplicabilityof
results from such trials is probably debatable.
Conclusions
In conclusion, the study highlights the poor reporting




trialtypesdidnot differin terms ofnumberand exper-
tise of centres and surgeons involved and the reprodu-
cibilityoftheintervention.Fromthesearticleswewere
unable to conclude whether the patients who partici-
pated were representative. The results of this study
need confirmation in other disciplines.
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